T lymphocytes can mediate lysis of autologous melanoma cells by multiple mechanisms: Evidence with a single T cell clone

[1]  E. Hersh,et al.  Phenotypic and functional analysis of lymphokine-activated killer (LAK) cell clones , 1989, Cancer Immunology, Immunotherapy.

[2]  D. Taramelli,et al.  Lack of suppressive activity of human primary melanoma cells on the activation of autologous lymphocytes , 2004, Cancer Immunology, Immunotherapy.

[3]  S. Ferrone,et al.  The monoclonal antibody CR11-351 discriminates HLA-A2 variants identified by T cells , 2004, Immunogenetics.

[4]  A. Anichini,et al.  Cytokine‐mediated modulation of HLA‐class II, ICAM‐1, LFA‐3 and tumor‐associated antigen profile of melanoma cells. comparison with anti‐proliferative activity by RIL1‐β, RTNF‐α, RIFN‐γ, RIl4 and their combinations , 1990 .

[5]  K. Meyer zum Büschenfelde,et al.  Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens , 1989, The Journal of experimental medicine.

[6]  A. Lanzavecchia,et al.  Triggering T cells by otherwise inert hybrid anti-CD3/antitumor antibodies requires encounter with the specific target cell , 1989, The Journal of experimental medicine.

[7]  A. Belldegrun,et al.  Human tumor infiltrating lymphocytes. Analysis of lymphokine mRNA expression and relevance to cancer immunotherapy. , 1989, Journal of immunology.

[8]  R. Supino,et al.  Generation and partial characterization of melanoma sublines resistant to lymphokine activated killer (LAK) cells. Relevance to doxorubicin resistance , 1989, International journal of cancer.

[9]  A. Anichini,et al.  Cytotoxic T lymphocyte clones from peripheral blood and from tumor site detect intratumor heterogeneity of melanoma cells. Analysis of specificity and mechanisms of interaction. , 1989, Journal of immunology.

[10]  B. Bonavida,et al.  Calcium-independent pathway of tumor necrosis factor-mediated lysis of target cells. , 1989, Journal of immunology.

[11]  E. Hersh,et al.  Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor. , 1989, Journal of immunology.

[12]  A. Stoppacciaro,et al.  Human natural cytotoxic activity mediated by tumor necrosis factor: regulation by interleukin-2. , 1988, Journal of the National Cancer Institute.

[13]  M. Moore,et al.  Simultaneous production of tumor necrosis factor-alpha and lymphotoxin by normal T cells after induction with IL-2 and anti-T3. , 1988, Journal of immunology.

[14]  G. Sozzi,et al.  Differential susceptibility to recombinant interferon-gamma-induced HLA-DQ antigen modulation among clones from a human metastatic melanoma. , 1987, Journal of immunology.

[15]  R. Schmidt,et al.  Characteristics and uses of natural killer cells. , 1988, Immunology today.

[16]  S. Rosenberg.  Immunotherapy of cancer using interleukin 2: current status and future prospects. , 1988, Immunology today.

[17]  P. Lipsky,et al.  Major histocompatibility complex-unrestricted cytolytic activity of human T cells. Analysis of precursor frequency and effector phenotype. , 1987, Journal of immunology.

[18]  Chau‐Ching Liu,et al.  Identification, isolation, and characterization of a novel cytotoxin in murine cytolytic lymphocytes , 1987, Cell.

[19]  M. Sitkovsky,et al.  Exocytosis of cytolytic granules may not be required for target cell lysis by cytotoxic T-lymphocytes , 1987, Nature.

[20]  H. Ostergaard,et al.  Cytotoxic T lymphocyte mediated lysis without release of serine esterase , 1987, Nature.

[21]  M. A. Saper,et al.  The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens , 1987, Nature.

[22]  M. Moore,et al.  Role of MHC class‐i antigens and the CD3 complex in the lysis of autologous human tumours by T‐cell clones , 1987, International journal of cancer.

[23]  T. Shiohara,et al.  Anti-tumor activity of class II MHC antigen-restricted cloned autoreactive T cells. I. Destruction of B16 melanoma cells mediated by bystander cytolysis in vitro. , 1987, Journal of immunology.

[24]  A. Lanzavecchia,et al.  The use of hybrid hybridomas to target human cytotoxic T lymphocytes , 1987, European journal of immunology.

[25]  A. Anichini,et al.  Clonal analysis of the cytolytic T-cell response to human tumors. , 1987, Immunology today.

[26]  T. Sayers,et al.  Analysis of cytostatic/cytotoxic lymphokines: relationship of natural killer cytotoxic factor to recombinant lymphotoxin, recombinant tumor necrosis factor, and leukoregulin. , 1986, Journal of immunology.

[27]  L. Lanier,et al.  Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis , 1986, The Journal of experimental medicine.

[28]  J. D. Young,et al.  Properties of a purified pore-forming protein (perforin 1) isolated from H-2-restricted cytotoxic T cell granules , 1986, The Journal of experimental medicine.

[29]  E. Podack,et al.  Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity , 1986, Cell.

[30]  K. Herold,et al.  Activation of lymphokine genes during stimulation of cloned T cells , 1986, European journal of immunology.

[31]  A. Anichini,et al.  Clonal analysis of cytotoxic T‐lymphocyte response to autologous human metastatic melanoma , 1985, International journal of cancer.

[32]  Bharat B. Aggarwal,et al.  Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin , 1984, Nature.

[33]  B. Aggarwal,et al.  Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity , 1984, Nature.

[34]  G. Trinchieri,et al.  Response of resting human peripheral blood natural killer cells to interleukin 2 , 1984, The Journal of experimental medicine.

[35]  H. Orr,et al.  Isolation of HLA locus-specific DNA probes from the 3'-untranslated region. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[36]  J. D. de Vries,et al.  A cloned human T cell line cytotoxic for autologous and allogeneic B lymphoma cells , 1984, The Journal of experimental medicine.

[37]  J. D. de Vries,et al.  Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity. , 1984, Journal of immunology.

[38]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[39]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.